The effect of bromocriptine on circulating vasopressin.
1. The oral administration of 2.5 mg of the dopamine (3,4-dihydroxyphenethylamine) agonist bromoergocriptine enhanced the osmotically stimulated rise in plasma [arginine]vasopressin ([Arg]VP) concentrations in five normal human subjects. 2. This finding lends support to the suggestion that the osmotically induced release of [Arg]VP is under dopaminergic control in man.
D000328:Adult; D001127:Arginine Vasopressin / Q000097:blood*; D001971:Bromocriptine / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D009994:Osmolar Concentration; D011388:Prolactin / Q000097:blood; D011863:Radioimmunoassay; D013997:Time Factors
D001127:Arginine Vasopressin; D001971:Bromocriptine; D011388:Prolactin